Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Varicella Zoster Virus encephalitis in Denmark from 2015 to 2019- A nationwide prospective cohort study

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Altered Immune Reconstitution in Allogeneic Stem Cell Transplant Recipients With Human Immunodeficiency Virus (HIV)

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Estimation of SARS-CoV-2 infection fatality rate by real-time antibody screening of blood donors

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Risk factors and Predictors of Mortality in Streptococcal Necrotizing Soft-Tissue Infections: A Multicenter Prospective Study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Hepatic steatosis associated with exposure to elvitegravir and raltegravir

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Knowledge of the epidemiology and clinical characteristics of Varicella zoster virus (VZV) encephalitis remains limited.

METHODS: Nationwide prospective cohort study of adults treated for microbiologically confirmed VZV encephalitis at Danish departments of infectious diseases from 2015 to 2019. Modified Poisson regression analysis was used to compute adjusted relative risks (RR) of unfavorable outcome.

RESULTS: We identified 92 adults (49% female) with VZV encephalitis yielding an incidence of 5.3/1,000,000/year (95% CI:4.2-6.6). The median age was 75 years (IQR 67-83) and immuno-compromising conditions were frequent (39%). Predominant symptoms were confusion (76%), headache (56%), nausea (45%), gait disturbance (42%), and personality changes (41%). Cranial imaging showed cerebral vasculitis (including infarction and hemorrhage) in 14 (16%) patients and encephalitic abnormalities in 11 (13%) with predilection for the brainstem and deep brain structures. Intravenous acyclovir treatment was initiated a median of 13.4 hours (IQR 5.2-46.3) since admission, while cranial imaging and lumbar puncture were performed after 6.3 hours (IQR 2.5-31.0) and 18.5 hours (IQR 4.9-42.0). In-hospital, 1-month, and 3-month mortalities were 4%, 9%, and 11%, respectively. Unfavorable outcome (Glasgow Outcome Score (GOS) of 1-4), was found in 69% at discharge, with age (adj. RR 1.02, 95% CI 1.01-1.03), vasculitis (adj. RR 1.38, 95% CI 1.02-1.86), and Glascow coma scale (GCS)<15 (adj. RR 1.32, 95% CI:1.01-1.73) identified as independent risk factors.

CONCLUSION: VZV encephalitis occurs primarily in elderly or immuno-compromised patients with a higher incidence than previously estimated. The diagnosis is often delayed and risk factors for unfavorable outcome are age, cerebral vasculitis, and GCS<15.

Original languageEnglish
JournalClinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN1058-4838
DOIs
Publication statusE-pub ahead of print - 27 Feb 2020

ID: 59544930